{
  "trial_id": "NCT02332447",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Adult patient (\u2265 18 years) suffering from drug-resistant partial epilepsy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient undergoing long-term video-EEG monitoring in one of the participating centre",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient who gave its written informed consent to participate to the study For randomization",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient who suffers a secondary generalized tonic-clonic seizure during the long-term video-EEG monitoring while being supervised by a nurse or a physician",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Age < 18 years",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient that has already been randomized in this study",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Pregnant or breastfeeding women",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Hypersensitivity to naloxone",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "History of severe heart disease (myocardial infarction, heart failure disorder, arrhythmia severe hypertension)",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has a history of severe intellectual disability, CHF, and epilepsy. He presented with facial twitching on the right and generalized shaking in his NH which required 20 mg valium to cease seizure activity.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT02332447",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}